{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:05:53Z","timestamp":1771657553564,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2018YFE0107600"],"award-info":[{"award-number":["2018YFE0107600"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2022YFC2304603"],"award-info":[{"award-number":["2022YFC2304603"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["Y21B020024"],"award-info":[{"award-number":["Y21B020024"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bmc.2025.118519","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T16:47:12Z","timestamp":1765471632000},"page":"118519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The development of anti-HIV agents targeting APOBEC3G\/Vif axis"],"prefix":"10.1016","volume":"134","author":[{"given":"Qiqi","family":"Bao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajia","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengjiao","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiwei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinlu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Cen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2025.118519_bb0005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.chom.2019.06.010","article-title":"The impact of HIV-1 drug escape on the global treatment landscape","volume":"26","author":"Collier","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bmc.2025.118519_bb0010","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nri1489","article-title":"Retroviral restriction by APOBEC proteins","volume":"4","author":"Harris","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bmc.2025.118519_bb0015","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41564-017-0063-9","article-title":"Deep sequencing of HIV-1 reverse transcripts reveals the multifaceted antiviral functions of APOBEC3G","volume":"3","author":"Pollpeter","year":"2018","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.bmc.2025.118519_bb0020","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1126\/science.1089591","article-title":"Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex","volume":"Vol. 302","author":"Yu","year":"2003","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.bmc.2025.118519_bb0025","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature10718","article-title":"T-cell differentiation factor CBF-\u03b2 regulates HIV-1 Vif-mediated evasion of host restriction","volume":"481","author":"Zhang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2025.118519_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115188","article-title":"Various strategies for developing APOBEC3G protectors to circumvent human immunodeficiency virus type 1","volume":"250","author":"Bao","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118519_bb0035","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1096\/fj.06-6773com","article-title":"Zinc chelation inhibits HIV Vif activity and liberates antiviral function of the cytidine deaminase APOBEC3G","volume":"21","author":"Xiao","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.bmc.2025.118519_bb0040","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/nbt.1496","article-title":"Small-molecule inhibition of HIV-1 Vif","volume":"26","author":"Nathans","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.bmc.2025.118519_bb0045","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1128\/JVI.06957-11","article-title":"Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC","volume":"86","author":"Zuo","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.bmc.2025.118519_bb0050","doi-asserted-by":"crossref","first-page":"16546","DOI":"10.1074\/jbc.M109.085308","article-title":"Small molecular compounds inhibit HIV-1 replication through specifically stabilizing APOBEC3G","volume":"285","author":"Cen","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2025.118519_bb0055","doi-asserted-by":"crossref","first-page":"8067","DOI":"10.1038\/s41598-018-26318-3","article-title":"Identification of small molecule compounds targeting the interaction of HIV-1 Vif and human APOBEC3G by virtual screening and biological evaluation","volume":"8","author":"Ma","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2025.118519_bb0060","doi-asserted-by":"crossref","DOI":"10.1128\/MMBR.00051-17","article-title":"Multiple inhibitory factors act in the late phase of HIV-1 replication: a systematic review of the literature","volume":"82","author":"G\u00e9linas","year":"2018","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.bmc.2025.118519_bb0065","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1741-7015-7-48","article-title":"Human cellular restriction factors that target HIV-1 replication","volume":"7","author":"Strebel","year":"2009","journal-title":"BMC Med"},{"key":"10.1016\/j.bmc.2025.118519_bb0070","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00144-19","article-title":"HIV-1 escape from small-molecule antagonism of Vif","volume":"10","author":"Sharkey","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.bmc.2025.118519_bb0075","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1099\/jgv.0.001026","article-title":"Novel host restriction factors implicated in HIV-1 replication","volume":"99","author":"Ghimire","year":"2018","journal-title":"J Gen Virol"},{"key":"10.1016\/j.bmc.2025.118519_bb0080","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41579-019-0225-2","article-title":"Restriction of HIV-1 and other retroviruses by TRIM5","volume":"17","author":"Ganser-Pornillos","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bmc.2025.118519_bb0085","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nature06553","article-title":"Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu","volume":"451","author":"Neil","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2025.118519_bb0090","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nature10117","article-title":"SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx","volume":"474","author":"Laguette","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2025.118519_bb0095","doi-asserted-by":"crossref","first-page":"18499","DOI":"10.1038\/srep18499","article-title":"A small molecule compound IMB-LA inhibits HIV-1 infection by preventing viral Vpu from antagonizing the host restriction factor BST-2","volume":"5","author":"Mi","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2025.118519_bb0100","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.antiviral.2011.07.007","article-title":"High-throughput assay to identify inhibitors of Vpu-mediated down-regulation of cell surface BST-2","volume":"91","author":"Zhang","year":"2011","journal-title":"Antiviral Res"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625004614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625004614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:25:01Z","timestamp":1771655101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625004614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":20,"alternative-id":["S0968089625004614"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118519","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The development of anti-HIV agents targeting APOBEC3G\/Vif axis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118519","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118519"}}